Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Revenue Growth (1y) (2023 - 2026)

Analysis

Fortrea Holdings (FTRE) Revenue Growth (1y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 8.74%
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 17.24%
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn -2.72%
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 1.20%
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -4.52%
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -48.49%
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn 11.98%
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -38.81%
10 VivoSim Labs 1.47 Mn 1.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.52%
Mar 31, 2026 -2.27%
Dec 31, 2025 -5.24%
Sep 30, 2025 3.91%
Jun 30, 2025 7.23%
Mar 31, 2025 -1.63%
Dec 31, 2024 -1.79%
Sep 30, 2024 -5.45%
Jun 30, 2024 -8.65%
Mar 31, 2024 -4.58%
Dec 31, 2023 41.21%
Sep 30, 2023 -6.36%
Jun 30, 2023 -8.57%